Clinical Trials Logo

Clinical Trial Summary

Taking the patients with chronic respiratory failure caused by COPD as the research object and the acute exacerbation of COPD as the main outcome index, the investigators hope to establish the syndrome differentiation and treatment scheme of COPD treated by traditional Chinese medicine, reduce the acute exacerbation of AECOPD, improve the clinical symptoms, improve the quality of life, reduce the mortality, preliminarily explore the mechanism of action, and lay the foundation for further research.


Clinical Trial Description

Chronic respiratory failure of chronic obstructive pulmonary disease belongs to the category of "lung distention", "asthma syndrome", "dyspnea" and "phlegm drink" in traditional Chinese medicine. According to traditional Chinese medicine, the pathology of this disease is mainly the dysfunction of lung ventilation. The basic pathogenesis is that the viscera are repeatedly affected by evil, the lung qi is damaged due to long-term disease, the lung function is damaged, the air mechanism is blocked, the application is publicized, the phlegm is turbid, the blood stasis is inevitable for a long time, and the lung qi is further damaged. The main clinical manifestations are shortness of breath, wheezing, shortness of breath, superficial shortness of breath and "drama of wheezing when moving", which may be accompanied by cough, expectoration, chest tightness, palpitation, lips, purple darkness, swelling of floating limbs, etc. The treatment of chronic respiratory failure patients with COPD can be significantly improved clinical symptoms such as shortness of breath and wheezing, reduce the number of acute exacerbations of patients, but there is still a lack of high-level evidence-based medicine research. Therefore, this project puts forward the hypothesis that "syndrome differentiation therapy can reduce AECOPD of COPD".It is proposed to adopt a multicenter, randomized, double-blind, placebo-controlled trial design, taking the patients with chronic respiratory failure caused by chronic obstructive pulmonary disease as the research object. The patients who meet the inclusion criteria, are divided into heart lung qi deficiency and lung kidney qi deficiency according to syndrome differentiation. The participants are randomly divided into the experimental group of 60 cases and the control group of 60 cases. The control group is given placebo treatment, and the experimental group is given Chinese medicine granules. The patients were followed up for 26 weeks. The main outcome indicators include the number of times of acute exacerbation of COPD, and the secondary outcome indicators include all-cause mortality, severity of acute exacerbation of COPD, clinical symptoms, CCQ score of COPD clinical questionnaire, quality of life score, dyspnea score, 6MWD, arterial blood gas analysis index, incidence and use time of mechanical ventilation, use time of oxygen therapy, serology index, health and economy Learning indicators, safety indicators, etc. To establish the TCM treatment scheme of chronic respiratory failure of COPD, reduce the acute aggravation of AECOPD, improve the clinical symptoms, improve the quality of life, reduce the mortality rate, preliminarily explore the mechanism of action, and lay the foundation for further research. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04694755
Study type Interventional
Source Henan University of Traditional Chinese Medicine
Contact Minghang Wang, doctor
Phone 18638392188
Email wmh107hn@163.com
Status Not yet recruiting
Phase Early Phase 1
Start date January 2021
Completion date October 2022

See also
  Status Clinical Trial Phase
Completed NCT05084976 - Parental Perception of COVID-19 Vaccine in Technology Dependent Patients
Not yet recruiting NCT05756387 - Improving Chronic Nocturnal Noninvasive Ventilation: a Multimodality Approach
Enrolling by invitation NCT04208581 - Yiqi Huoxue Huatan Granule for Reducing Mortality in COPD With Chronic Respiratory Failure Phase 3
Recruiting NCT02260583 - Effect of Extracorporeal CO2 Removal in Stable Hypercapnic COPD Patients N/A
Completed NCT01255111 - Adaptation to Nocturnal Noninvasive Ventilation in Patients With Chronic Respiratory Failure (ROOMILA) N/A
Active, not recruiting NCT03499470 - Structured Discharge and Follow-up Protocol for COPD Patients Receiving LTOT and NIV N/A
Completed NCT04143230 - Identification of In-hospital Patients in Need of Palliative Care Using a New Simplified Screening Tool N/A
Terminated NCT00208078 - Effect of Non-Invasive Ventilation in Cystic Fibrosis Patient With Chronic Respiratory Failure. Phase 4
Recruiting NCT06286917 - Initiation of Noninvasive Ventilation in ALS Patients With Chronic Respiratory Insufficiency N/A
Completed NCT02342899 - Cost Effectiveness of Outpatient Set-up of Automated NIV in Obese Patients With Chronic Respiratory Failure Phase 3
Terminated NCT03473171 - Implementation of Nasal Non-Invasive Ventilation With a RAM Cannula in the Inpatient /Outpatient Setting N/A
Not yet recruiting NCT05258370 - Fibroblast Growth Factor 23 in Chronic Respiratory Failure
Completed NCT02804243 - The Efficacy of Nasal High Flow Oxygen Therapy With Rehabilitation in the Patients With Chronic Respiratory Failure N/A
Completed NCT01479959 - Impact of Patient Controlled Positive End-expiratory Pressure on Speech in Tracheostomized Ventilated Patients N/A
Completed NCT01090986 - Home Mechanical Ventilation Effectiveness and Air Leaks N/A
Completed NCT00698958 - Ambulatory Adaptation to Non-Invasive Mechanical Ventilation Phase 4
Not yet recruiting NCT06119087 - Mechanical Insufflation in the Philadelphia Amyotrophic Lateral Sclerosis Cohort (MI-PALS) Study N/A
Recruiting NCT05796297 - Clinical Impact of Patient-ventilator Asynchrony
Recruiting NCT04481295 - Study on Optimal Oxygen Concentration During Pulmonary Rehabilitation N/A
Withdrawn NCT05379439 - Family Connections N/A